Stock falls on serious case update. What is happening? https://thefly.com/landingPageNews.php?id=2823917&headline=NBIX-Neurocrine-slides-as-Ingrezza-serious-cases-count-updated-in-FDA-system
Ok what the heck is going on here. I’m about to accept an offer but this sounds like a serious red flag.
Read deeper. It does not link deaths to a drug... consider death by another cause while happening to take a drug.
According to my psychs, Neurocrine is back to lying about Austedo again. They know we don't have a black box for suicidal ideation or behavior in the Tardive population. We have already debunked your lies with facts/proof and our MSLs. They know you people lie and they talk about it. If one more provider tells me you are peddling this blatant lie again, a formal complaint will be lodged against the company and the rep.
We don’t need to lie about your drug. It’s a second line product and numbers and market share show it. Majority of your RX is because you have preferred coverage bc your company bent over at the negotiating table. Also, didn’t a large group of reps and managers just get fired from Teva for shady sales tactics? Pot calling the kettle?
You guys are lying about Austedo daily. You know it. The only supposed benefit you may have is once a day dosing. That's it.
My physicians aren't either. I tried telling them it's a class affect, but they are seeing Parkinsonism with Ingrezza way too much.
My speaker is very upset about this PI change. He has read the fine print about severity and hospitalizations.
whats a few deaths! Think of all the people we are helping! Also, we have our profits to consider. Ssshhhhh! Keep all of this on the down low!